Partech Ventures Supports French Lending Platform Lendix

  • Investment Management , Alternative Finance
  • 26.04.2016 11:00 am

Partech Ventures confirms its support of Lendix, the French number one in lending platforms, as CNP Assurances, MatMut and ZenCap AM join as new investors.

“Partech Ventures has supported Lendix since its launch in 2014, and is confirming its commitment with a 3 million euro follow-on investment in this round”,explains Philippe Collombel, Co-Managing Partner of Partech Ventures and a member of Lendix’s Supervisory Board. “In 12 months, the platform has reached the number one position in France and shows all of the attributes needed for quick international growth, which we are thrilled to support.”

Since its first loan in April 2015 to Alain Ducasse Entreprise, Lendix has taken real leadership on the market of SMB loans, becoming number one in France with a 40% market share. The platform has made it possible for about a hundred companies of all sizes to borrow more than €20M (excluding the recent Finsquare acquisition) for loans ranging from €30,000 to €1M. Lendix aims to grant over €50M in loans on its platform over the next 12 months on the French, Spanish and Italian markets.

‘Since our launch in 2014, the loyal and active support of Partech Ventures has been a key asset in our rapid development, says Olivier Goy, Founder and Chief Executive Officer of Lendix. “Their renewed confidence and teams’ experience in internationalizing high-growth companies will allow us to have an edge as we expand in Spain and Italy.”

This new investment illustrates Partech Ventures’ ability to finance the very high growth and internationalization of the companies in which it invests, as with its investments in TeadsKantoxFreedomPopMade.com and M-Files.

It also confirms the major role that Partech Ventures has taken in financing leading Fintech companies, with a dozen investments including Compte-Nickel andLendix (Paris), GetSafe (Heidelberg), XfersAscend, and Xendit (San Francisco), The Guarantors and Atlas (New York), KantoxNovicap and Eris (London). 

 

Related News